Your browser doesn't support javascript.
loading
Erratum to: Pathologic Complete Response to Intralesional Interleukin-2 Therapy Associated with Improved Survival in Melanoma Patients with In-Transit Disease.
Hassan, Saima; Petrella, Teresa M; Zhang, Tong; Kamel-Reid, Suzanne; Nordio, Francesco; Baccarelli, Andrea; Sade, Shachar; Naert, Karen; Al Habeeb, Ayman; Ghazarian, Danny; Wright, Frances C.
Afiliação
  • Hassan S; Division of Surgical Oncology, Sunnybrook Health Sciences Centre, Odette Cancer Centre, Toronto, ON, Canada. saimanoorhassan@gmail.com.
  • Petrella TM; Department of Biomedical Engineering, Oregon Health and Science University, Portland, OR, USA. saimanoorhassan@gmail.com.
  • Zhang T; Division of Medical Oncology, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
  • Kamel-Reid S; Department of Pathology, University Health Network, Toronto, ON, Canada.
  • Nordio F; Department of Pathology, University Health Network, Toronto, ON, Canada.
  • Baccarelli A; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.
  • Sade S; Department of Environmental Health and Epidemiology, Harvard School of Public Health, Boston, MA, USA.
  • Naert K; Department of Pathology, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
  • Al Habeeb A; Department of Pathology, University Health Network, Toronto, ON, Canada.
  • Ghazarian D; Department of Pathology, University Health Network, Toronto, ON, Canada.
  • Wright FC; Department of Pathology, University Health Network, Toronto, ON, Canada.
Ann Surg Oncol ; 22 Suppl 3: S1603, 2015 Dec.
Article em En | MEDLINE | ID: mdl-25503348

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Ano de publicação: 2015 Tipo de documento: Article